Shorter Clopidogrel Therapy Not Superior following Coronary DES Implantation

Summary

In the Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation trial [ISAR-TRIPLE; NCT00776633], 6 weeks of triple therapy including the oral antiplatelet compound clopidogrel is not superior to a 6-month regimen following implantation of a drug-eluting stent.

  • Interventional Techniques & Devices
  • Thrombotic Disorders
  • Cardiology Clinical Trials
  • Interventional Techniques & Devices
  • Thrombotic Disorders
  • Cardiology
  • Cardiology Clinical Trials
View Full Text